"Okay, Richard, I think we are here. Scott must have told you before, so I won't go around in circles, so as not to waste everyone's time. Can you introduce to us first, do you usually work in Dularick? What are you mainly responsible for? I heard from Scott that you are mainly responsible for R&D, so what medicine have you all developed?"

Jin Muchen asked Richard with a smile, and for some reason, this young Chinese man looked less than thirty years old, but sitting in front of him, Richard could actually feel the uneven and arrogant temperament that was emitting from him.

After being in the workplace for many years, Richard certainly knew what kind of person would have such a momentum. It must be the kind of superior who has been in high positions for a long time that naturally bears such a halo.

When facing such people, you'd better be careful, because if you don't know what you said, you will be unhappy. If these people are unhappy, the consequences will often be very serious.

What's more, his friend Scott repeatedly introduced to him that these two people are quite good. If they can perform well in front of them this time, they may not have to work on the West Coast anymore, and they can even move their whole family to China.

If Richard had been killed, he might not want to leave the United States, and he would not want to go to China, but in the current market environment, going to China might be a very good choice. After all, being able to go to China means that his position can be improved and his salary will definitely increase. This is very important to him. After all, there is still a large number of people to support him.

"Well, Mr. Jin, Mr. Wang, I'll give you a formal self-introduction. My name is Richard Torrey, a native of San Francisco. My university is really a major in pharmacology at Haval University. After graduation, I returned to the West Coast and have been working in this Dularic company. I started from the grassroots level and am now the director of the broad-spectrum antibacterial department of Dularic company. I have worked in this position for five years. As for you, if you ask me, do you have any new research and development in this company... I'm sorry..."

When he said this, Richard paused helplessly and smiled bitterly, and then continued: "You should all know about the experience of Dularick Company. It was acquired by Amgen a few years ago, but since it was acquired by Amgen, the company has changed its flavor. In the past, this company was quite enterprising company, and it had great ambitions and ambitions in the research of new drugs. However, since it was controlled by Amgen, the company has lost its ambitions because it has differences in its business direction, and the company's annual scientific research funding is limited.

It turns out that our market in the San Francisco area has gradually been eroded by other large pharmaceutical companies. So in the past few years, I have no results at all. My research department head is just a blank title. The main job I do now is not research and development, but to study and understand how to make a good replica. When other companies’ patent protection drugs expire, we must study and understand how they produce them and then copy them, and put such replicas into the market as soon as possible..."

Richard is really honest and direct enough. When he said this, Jin Muchen and Wang Xueming couldn't help but look at this guy more. In today's society, especially in the workplace veterans like him, there are not many such honest people.

What made Jin Muchen and Wang Xueming even more happy was that when Richard heard the tone of this, he seemed not very satisfied with Anjin's strategy.

This is a good thing for Jin Muchen and Wang Xueming. After all, the main purpose of their visit to San Francisco this time is to poach. If there are many people in this company, like Richard, who are dissatisfied with Amgen, it will be very beneficial to their poaching work.

"Then how good are your business? Well... I might be a bit pretentious to ask this question, but I hope you don't mind. We really want to know what level of your Dularic company is in terms of generic drugs? How much difference is your generic drug with the original drug? And what type of broad-spectrum antibiotics are you focusing on?"

Jin Muchen asked Richard again, and this question was also crucial, because the people they were going to dig back were mainly those who produced these antibiotics.

Because many broad-spectrum antibiotics in China have basically entered the second generation. In the 1980s, when the domestic antibiotics were not used in the country, the main antibiotics used in China's domestic pharmaceutical market were oleracycin, penicillin, erythromycin, tetracycline and other antibiotics.

However, after entering the new century, with the abuse of various antibiotics, the bacteria in the patient population in China have developed very strong drug resistance, and the second-generation antibiotics from abroad have also begun to be introduced in China.

This antibiotic includes azithromycin and rosomycin, and the pioneers of the current era, which are the cephalexin antibiotics that we commonly use on the market.

Especially the antibiotics of cephalene, many different types of antibiotics have been derived, and such antibiotics are the broad-spectrum antibiotics with the most widely used and most effective drugs in the domestic pharmaceutical market.

Such drugs have basically passed the patent protection period internationally. Many domestic pharmaceutical factories can produce such antibiotics, but this is also the biggest gap between us and the international community.

The same antibiotic is the same as our domestic pharmaceutical factory, even if it has the best technology and the largest brand, the cephalenic series antibiotics produced by the state-owned pharmaceutical factory, but the efficacy of the drug can barely reach about 70% of the same type of antibiotics abroad.

That is, this 30% gap makes the price of domestic cephalexin antibiotics and imported cephalexin antibiotics dozens of times. Some antibiotics specifically used for certain types of special surgery can even exceed hundreds of times.

The price gap in this part is exactly what Jin Muchen and Wang Xueming are concerned about. If they can build such a pharmaceutical factory in China and specialize in producing antibiotics with similar efficacy as foreign pharmaceutical factories, then when they promote it in China, and Wang Xueming's off-site background, it will be much easier.

It is just around the corner for pharmaceutical companies to become bigger and stronger.

The key to making such an antibiotic equivalent to that produced by a foreign pharmaceutical factory is that experienced engineers and pharmacists, to put it bluntly, are people like Richard.

It is precisely because of this that Jin Muchen went straight to ask such questions.

And his problems happened to hit Richard's itch. He worked in Dularick for more than ten years and hadn't done real research and development several times, but he could definitely be familiar with replicant drugs.

Moreover, he has a legacy in this industry, because their family has worked in the Dularic company for several generations.

"Tell you so, Mr. Jin, our family has worked in Dularick Company since my grandfather, and Dularick Company was established at the end of World War II. At that time, they specialized in producing replicant drugs. My grandfather was the director of the technical department of this company at that time. He was very kind in the technology of replicant drugs. Later, this position was passed to my father and later to me. So in the field of replicant drugs, our family has great experience. Now I don't exaggerately say that as long as it is the drugs on the market that have passed the patent protection period, we can do it unless some drugs that require special technical means and tools. Any ordinary drugs are nothing I can't do, and I can guarantee that the replicant drugs we produce can almost be compared with the original on the market.

The drug version has 100% effect, and some drugs are even better than the original one. This is also the main reason why Dularique Company was able to stand in the San Francisco area after the 1980s. Our Dularique Company was quite famous in Northern California at that time. There were many hospitals using our drugs in the San Francisco region, even the southernmost part of the Los Angeles region, and even to St. Jones. Of course, this is also the main reason why Amgen was willing to spend a lot of money to acquire our company. But I just don’t understand what the leaders of Amgen were thinking? They spent more than one billion to acquire our company, but in the end they ruined our company in vain. Could it be that they were really just for fun?”

When talking about the field of replicant drugs, Richard became energetic. Their family has passed on several generations of replicant drugs, and even has many unique skills. This is also the main reason why their family members can be in charge of Dularick's replicant drug department for three generations.

Moreover, what he said is not an exaggeration. The drugs copied from their family are really effective. Some are not only not inferior to the original drugs, but are even better than the original drugs.

Unfortunately, in the end, all these were corrupted by the leaders of Amgen, which also made him very resentful about Amgen.
Chapter completed!